Retention of albumin in rosiglitazone treatment and further decrease in microalbuminuria is good indication for diabetic patients. However, the several contradictory reports on its adverse side effects like fluid retention and increase in cardio vascular disease are a matter of concern as it is leading to several ambiguities of rosiglitazone treatment. To reduce cardiovascular side effects of glitazones, antihypertensive drug such as valsartan are employed. Since albumin interaction is an important parameter in pharmacokinetic and drug efficacy, we intended to perform in-vitro experiments on albumin-rosiglitazone/valsartan interaction. Different spectroscopic techniques such as steady state fluorescence, time resolved fluorescence, circular dichroism, dynamic scattering and infrared spectroscopy have been employed to explore the interaction of drug with serum albumin. Stoichiometry of the complex formed between albumin-rosiglitazone was found to increase with increase in temperature suggested self-association of albumin which was confirmed by DLS. Circular dichroism study revealed that the secondary structure of albumin is modified on drug interaction. In silico study suggest that binding rosiglitazone to the BSA site I and II could be the prime reason behind self-association which leads to oligomerisation.
Journal of Luminescence – Elsevier
Published: May 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera